Omthera Pharmaceuticals, Inc. (OMTH) [Rocket]

Overview

Omthera Pharmaceuticals, Inc. (OMTH)

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
07/29/2013	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]
07/23/2013	SC 13D/A	NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Omthera Pharmaceuticals, Inc.
07/22/2013	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/18/2013	8-K	Quarterly results
07/18/2013	4	Form 4 - Statement of changes in beneficial ownership of securities
07/18/2013	4	BARRETT M JAMES (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.
07/18/2013	4	BASKETT FOREST (10% Owner) has filed a Form 4 on Omthera Pharmaceuticals, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-12	Dec-31-11
Revenues	22.7	21.2
Revenue growth	6.9%
Cost of goods sold	22.7	21.2
Gross profit	0.0	0.0
Gross margin	0.0%	0.0%
General and administrative	4.9	3.7
EBIT	-27.6	-24.9
EBIT margin	-121.7%	-117.6%
Pre-tax income	-27.6	-24.9
Income taxes	0.0	0.0
Tax rate	0.0%	0.0%
Net income	-27.6	-24.9
Net margin	-121.6%	-117.6%

Diluted EPS	($14.41)	($20.39)
Shares outstanding (diluted)	1.9	1.2

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy